Literature DB >> 26967556

Multimodal CT techniques for cerebrovascular and hemodynamic evaluation of ischemic stroke: occlusion, collaterals, and perfusion.

Baixue Jia1,2,3,4, Fabien Scalzo5, Elijah Agbayani6, Graham W Woolf5, Liping Liu2,3,4,7, Zhongrong Miao1,2,3,4, David S Liebeskind8.   

Abstract

Neuroimaging of cerebrovascular status and hemodynamics has vastly improved our understanding of stroke mechanisms and provided information for therapeutic decision-making. CT techniques are the most commonly used techniques due to wide availability, rapid acquisition and acceptable tolerance. Numerous multimodal CT techniques have been developed in the last few years. We summarize and explain the various multimodal CT acquisition techniques within three categories based on the scanning mode, namely static mode (single-phase CTA), multiple static mode (multi-phase CTA) and continuous mode (CT perfusion and dynamic CTA). Post-processing methods based on different acquisition modes are also introduced in an easy manner by focusing on the information extracted and products generated. We also describe the applications for these techniques along with their advantages and disadvantages.

Entities:  

Keywords:  CT angiography; CT perfusion; Computed tomography technique; cerebral vascular; collateral; hemodynamics

Mesh:

Year:  2016        PMID: 26967556     DOI: 10.1586/14737175.2016.1165094

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  2 in total

Review 1.  Mapping the collaterome for precision cerebrovascular health: Theranostics in the continuum of stroke and dementia.

Authors:  David S Liebeskind
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-30       Impact factor: 6.200

2.  Correlation Between Chest CT Findings and Clinical Features of 211 COVID-19 Suspected Patients in Wuhan, China.

Authors:  Songlin Song; Feihong Wu; Yiming Liu; Hongwei Jiang; Fu Xiong; Xiaopeng Guo; Hongsen Zhang; Chuansheng Zheng; Fan Yang
Journal:  Open Forum Infect Dis       Date:  2020-05-16       Impact factor: 3.835

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.